Moreover, liver-specific AMPK knockout mice exhibited more severe pathology characteristic of NAFLD, including enhanced hepatic steatosis, oxidative stress, liver function damage and inflammatory responses, which indicated that AMPK is a potential target for the treatment and prevention of NAFLD (Strzyz, 2020). The gene discussed is PRKAA1; the disease is fatty liver disease.